Advanced search
Publication Cover
Expert Opinion on Therapeutic Patents Volume 32, 2022 - Issue 2
Submit an article Journal homepage
2,149
Views
7
CrossRef citations to date
0
Altmetric
Review

Ligands for cereblon: 2017–2021 patent overview

Alexander KazantsevInstitute of Chemistry, Saint Petersburg State University, Saint Petersburg, Russian FederationView further author information
&
Mikhail KrasavinInstitute of Chemistry, Saint Petersburg State University, Saint Petersburg, Russian FederationCorrespondence[email protected]
View further author information
Pages 171-190 | Received 01 Sep 2021, Accepted 25 Oct 2021, Published online: 08 Nov 2021

Citations (7)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

André T. S. Vicente & Jorge A.R. Salvador. (2023) Proteolysis-Targeting Chimeras (PROTACs) targeting the BCR-ABL for the treatment of chronic myeloid leukemia – a patent review. Expert Opinion on Therapeutic Patents 33:6, pages 397-420.
Read now

Articles from other publishers (6)

Haibo Xie, Chunrong Li, Hua Tang, Ira Tandon, Junzhuo Liao, Brett L. Roberts, Yu Zhao & Weiping Tang. (2023) Development of Substituted Phenyl Dihydrouracil as the Novel Achiral Cereblon Ligands for Targeted Protein Degradation. Journal of Medicinal Chemistry 66:4, pages 2904-2917.
Crossref
Antara Chakravarty & Priscilla L. Yang. (2023) Targeted protein degradation as an antiviral approach. Antiviral Research 210, pages 105480.
Crossref
Maria Adamchik, Andrey Bubyrev, Daniil Zhukovsky, Petr Zhmurov, Alexander Bunev & Mikhail Krasavin. (2023) Synthesis of novel glutarimide derivatives via the Michael addition of (hetero)aromatic thiols: pronounced effect of sulfur oxidation on cytotoxicity towards multiple myeloma cell lines. Mendeleev Communications 33:1, pages 67-69.
Crossref
Darina Barkhatova, Daniil Zhukovsky, Christopher Heim, Samuel Maiwald, Marcus D. Hartmann & Mikhail Krasavin. (2022) Synthesis of novel glutarimide derivatives via the Ugi multicomponent reaction: affinity towards the E3 ubiquitin ligase substrate receptor Cereblon. Mendeleev Communications 32:6, pages 747-749.
Crossref
Charles E. Hendrick, Jeff R. Jorgensen, Charu Chaudhry, Iulia I. Strambeanu, Jean-Francois Brazeau, Jamie Schiffer, Zhicai Shi, Jennifer D. Venable & Scott E. Wolkenberg. (2022) Direct-to-Biology Accelerates PROTAC Synthesis and the Evaluation of Linker Effects on Permeability and Degradation. ACS Medicinal Chemistry Letters 13:7, pages 1182-1190.
Crossref
Olga Bakulina, Alexander Sapegin, Alexander S. Bunev & Mikhail Krasavin. (2022) Synthetic approaches to constructing proteolysis targeting chimeras (PROTACs). Mendeleev Communications 32:4, pages 419-432.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.